Articles related to Neurology

Primary CNS vasculitis affects an estimated 2.4 cases per 1 million person-years, presenting a significant diagnostic and therapeutic challenge for neurologists and rheumatologists.

Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.

Recent research comparing SGLT2 inhibitors and dulaglutide in older patients with type 2 diabetes suggests a potential difference in dementia risk. The study estimated a risk ratio of 0.81 (CI, 0.56 to 1.16) for SGLT2 inhibitors compared to dulaglutide.

Recent studies suggest that ALS may begin to develop shortly after conception, taking years or decades before symptoms appear, highlighting the importance of early intervention and lifestyle modifications.

The introduction of lisdexamfetamine, a generic for Vyvanse, initially showed promise in increasing access to ADHD treatment. However, it too has fallen into shortage, highlighting the ongoing challenges in meeting patient demand.

Changes to blood-based biomarkers can be detected before Alzheimer’s symptoms appear, potentially allowing for earlier intervention and more targeted treatment approaches.